Cargando…

GnRH Antagonist Protocol With Cessation of Cetrorelix on Trigger Day Improves Embryological Outcomes for Patients With Sufficient Ovarian Reserve

OBJECTIVE: To evaluate the efficiency and validity of cessation of cetrorelix on trigger day during gonadotropin releasing hormone antagonist (GnRH-ant)-controlled ovarian stimulation of in vitro fertilization (IVF) cycles. METHODS: In this retrospective study, a total of 1271 patients undergoing in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Huihui, Zhao, Shen, Gao, Xinxing, Wu, Xian, Xia, Lan, Zhang, Dan, Li, Jian, Zhang, Aijun, Xu, Bufang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551826/ https://www.ncbi.nlm.nih.gov/pubmed/34721305 http://dx.doi.org/10.3389/fendo.2021.758896

Ejemplares similares

Flexible Low-Dose GnRH Antagonist Protocol Is Effective in Patients With Sufficient Ovarian Reserve in IVF
por: Zhang, Dan, et al.
Publicado: (2018)

Adverse Effects of Vincristine Chemotherapy on Cell Changes in Seminiferous Tubules and Cetrorelix GnRH Antagonist Inhibitory Effects in Mice
por: Nikpour, Fatemeh, et al.
Publicado: (2018)

Down-regulation of S100P induces apoptosis in endometrial epithelial cell during GnRH antagonist protocol
por: Zhang, Dan, et al.
Publicado: (2021)

Efficacy and Safety of gonadotropin-releasing hormone (GnRH) Agonists Triptorelin Acetate and Cetrorelix Acetate in Assisted Reproduction
por: Jiang, Jingjing, et al.
Publicado: (2018)

Increased Uterine NK cell numbers and perforin expression during the implantation phase in IVF Cycles with GnRH Antagonist Protocol
por: Xu, Bufang, et al.
Publicado: (2017)

Comparison of GnRH Agonist, GnRH Antagonist, and GnRH Antagonist Mild Protocol of Controlled Ovarian Hyperstimulation in Good Prognosis Patients
por: Stimpfel, Martin, et al.
Publicado: (2015)

GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology
por: Cota, Ana Marcia M, et al.
Publicado: (2012)

Comparison of long GnRH agonist versus GnRH antagonist protocol in poor responders
por: Şahin, Sadık, et al.
Publicado: (2014)

GnRH Antagonists Produce Differential Modulation of the Signaling Pathways Mediated by GnRH Receptors
por: Sperduti, Samantha, et al.
Publicado: (2019)

GnRH agonist long protocol versus GnRH antagonist protocol for various aged patients with diminished ovarian reserve: A retrospective study
por: Huang, Ming-Chao, et al.
Publicado: (2018)

GnRH agonist versus GnRH antagonist in in vitro fertilization and embryo transfer (IVF/ET)
por: Depalo, Raffaella, et al.
Publicado: (2012)

Cost-effectiveness analysis of GnRH-agonist long-protocol and GnRH-antagonist protocol for in vitro fertilization
por: Jing, Miaomiao, et al.
Publicado: (2020)

GnRH Antagonist IVF Protocol in PCOS
por: Onofriescu, Alina, et al.
Publicado: (2013)

Comparisons of GnRH antagonist protocol versus GnRH agonist long protocol in patients with normal ovarian reserve: A systematic review and meta-analysis
por: Wang, Ruolin, et al.
Publicado: (2017)

Ovarian stimulation in IVF couples with severe male factor infertility: GnRH antagonist versus long GnRH agonist
por: Lv, Mu, et al.
Publicado: (2022)

Stop GnRH-agonist/GnRH-antagonist protocol: a different insight on ovarian stimulation for IVF
por: Orvieto, Raoul
Publicado: (2023)

A Flexible Multidose GnRH Antagonist versus a Microdose Flare-Up GnRH Agonist Combined with a Flexible Multidose GnRH Antagonist Protocol in Poor Responders to IVF
por: Turgay Çelik, Gayem İnayet, et al.
Publicado: (2015)

Microdose GnRH Agonist Flare-Up versus Ultrashort GnRH Agonist Combined with Fixed GnRH Antagonist in Poor Responders of Assisted Reproductive Techniques Cycles
por: Eftekhar, Maryam, et al.
Publicado: (2013)

Assessment of fertility protection and ovarian reserve with GnRH antagonist in rats undergoing chemotherapy with cyclophosphamide
por: Lemos, Claudia NCD, et al.
Publicado: (2010)

Early-cleavage is a reliable predictor for embryo implantation in the GnRH agonist protocols but not in the GnRH antagonist protocols
por: Yang, Wen-Jui, et al.
Publicado: (2009)

Recent Development of Non-Peptide GnRH Antagonists
por: Tukun, Feng-Ling, et al.
Publicado: (2017)

GnRH antagonist treatment of malignant adrenocortical tumors
por: Doroszko, Milena, et al.
Publicado: (2018)

Comparison of two different starting dose of rhFSH in GnRH antagonist protocol for patients with normal ovarian reserve
por: Jia, Zhi-cheng, et al.
Publicado: (2023)

Gonadotropin-Releasing Hormone (GnRH) Receptor Structure and GnRH Binding
por: Flanagan, Colleen A., et al.
Publicado: (2017)

The role of GnRH metabolite, GnRH-(1-5), in endometrial cancer
por: Cho-Clark, Madelaine J., et al.
Publicado: (2023)

A prospective study of GnRH long agonist versus flexible GnRH antagonist protocol in PCOS: Indian experience
por: Kaur, Harpreet, et al.
Publicado: (2012)

Comparison of GnRH agonist versus luteal estradiol GnRH antagonist protocol using transdermal testosterone in poor responders
por: Fàbregues, Francesc, et al.
Publicado: (2019)

Pregnancy outcome of “delayed start” GnRH antagonist protocol versus GnRH antagonist protocol in poor responders: A clinical trial study
por: Aflatoonian, Abbas, et al.
Publicado: (2017)

Melatonin Inhibits GnRH-1, GnRH-3 and GnRH Receptor Expression in the Brain of the European Sea Bass, Dicentrarchus labrax
por: Servili, Arianna, et al.
Publicado: (2013)

Cost-effectiveness of GnRH antagonist implementation on hCG injection day
por: Özdemir, Ayşe Zehra, et al.
Publicado: (2019)

Optimal usage of the GnRH antagonists: a review of the literature
por: Copperman, Alan B, et al.
Publicado: (2013)

Investigation of the GnRH antagonist degarelix isomerization in biological matrices
por: Ferrazzano, Lucia, et al.
Publicado: (2023)

GnRH agonist trigger versus hCG trigger in GnRH antagonist in IVF/ICSI cycles: A review article
por: Alyasin, Ashraf, et al.
Publicado: (2016)

Outcomes of a GnRH Agonist Trigger Following a GnRH Antagonist or Flexible Progestin-Primed Ovarian Stimulation Cycle
por: Kalafat, Erkan, et al.
Publicado: (2022)

Gonadotropin-Releasing Hormone (GnRH)/GnRH Receptors and Their Role in the Treatment of Endometriosis
por: Resta, Christina, et al.
Publicado: (2023)

Estradiol pretreatment in GnRH antagonist protocol for IVF/ICSI treatment
por: Zhu, Shaomi, et al.
Publicado: (2022)

Effect of Pre-ovulatory Single Dose GnRH agonist Therapy on IVF Outcome in GnRH Antagonist Cycles; A Prospective Study
por: Kaur, Harpreet, et al.
Publicado: (2012)

Cumulus Cells Gene Expression Profiling in Terms of Oocyte Maturity in Controlled Ovarian Hyperstimulation Using GnRH Agonist or GnRH Antagonist
por: Devjak, Rok, et al.
Publicado: (2012)

Treatment with a GnRH receptor agonist, but not the GnRH receptor antagonist degarelix, induces atherosclerotic plaque instability in ApoE(−/−) mice
por: Knutsson, Anki, et al.
Publicado: (2016)

GnRH agonist in association with hCG versus hCG alone for final oocyte maturation triggering in GnRH antagonist cycles
por: de Oliveira Filho, Condesmar M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3sfp0ojq78ldfu6s916ci0g6ov